This systematic review and meta-analysis offer a comprehensive overview of the key genetic alterations in differentiated and anaplastic thyroid cancer, highlighting the clinical significance of mutations in BRAF, TERT, TP53, and PI3K pathway genes. This evidence concerns the gene BRAF and thyroid gland undifferentiated (anaplastic) carcinoma.